Key terms
About SENS
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SENS news
Mar 25
4:23pm ET
Senseonics Board Shift: Schumm Out, Hansen In Until 2025
Mar 11
6:40am ET
Analysts Offer Insights on Healthcare Companies: Trevena (TRVN), MoonLake Immunotherapeutics (MLTX) and Senseonics Holdings (SENS)
Mar 01
7:50am ET
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS), Azitra Inc (AZTR) and Dexcom (DXCM)
Mar 01
7:50am ET
Stifel Nicolaus Sticks to Its Buy Rating for Senseonics Holdings (SENS)
Mar 01
7:03am ET
Senseonics Holdings (SENS) Receives a Hold from BTIG
Feb 29
4:25pm ET
Senseonics reports FY23 EPS (11c), consensus (12c)
Feb 29
7:05am ET
Options Volatility and Implied Earnings Moves Today, February 29, 2024
Feb 12
7:04am ET
Senseonics’ Eversense 33 CGM system expands Medicare coverage
Jan 03
10:15am ET
Stifel Nicolaus Reaffirms Their Buy Rating on Senseonics Holdings (SENS)
Jan 02
4:07pm ET
Senseonics sees Q4 revenue of about $8.0M, consensus $7.5M
Jan 02
9:50am ET
BTIG Sticks to Their Hold Rating for Senseonics Holdings (SENS)
Dec 31
5:26am ET
Senseonics Holdings (SENS) Receives a Hold from BTIG
No recent press releases are available for SENS
SENS Financials
Key terms
Ad Feedback
SENS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SENS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
